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Abstract 
Short Communication on t(7;9)(q11.2;p13.2) 
PAX5/AUTS2, with data on clinics, and the genes 
implicated. 
Clinics and pathology 
Disease 
B-cell precursor acute lymphoblastic leukemia 
(BCP-ALL) 
Epidemiology 
This unbalanced chromosomal rearrangement was 
found in three pediatric patients with B-cell 
precursor acute lymphoblastic leukemia (Kawamata 
et al., 2008; Coyaud et al., 2010a; Denk et al., 
2012). 
Clinics 
All three patients achieved a complete remission 
(CR) after completion of induction therapy; 
however, two of the patients experienced an early 
relapse and both patients died, one from an 
infectious complication in second CR and one from 
progressive leukemia after a further relapse.  
The third patient remains in first CR for more than 
two years after diagnosis (Denk et al., 2012). 
Genes involved and 
proteins 
PAX5 
Location 
9p13.2 
 
 
DNA/RNA 
10 exons, alternatively spliced transcript variants 
encoding different isoforms. 
Protein 
PAX5 is a transcription factor harboring a 
conserved paired box DNA-binding domain.  
It is a master regulator of B-cell commitment and 
maintenance and within the hematopoietic system is 
expressed in B-cells from the pro-B cell to the 
mature B-cell stage and repressed upon plasma cell 
differentiation (Cobaleda et al., 2007; Medvedovic 
et al., 2011).  
In BCP-ALL PAX5 is a frequent target of somatic 
mutations, comprising deletions, point mutations, 
and structural rearrangements resulting in the 
expression of fusion transcripts (Mullighan et al., 
2007).  
To date, 16 different in-frame PAX5 fusions genes 
have been reported in B-ALL (Cazzaniga et al., 
2001; Bousquet et al., 2007; Mullighan et al., 2007; 
Nebral et al., 2007; Kawamata et al., 2008; Nebral 
et al., 2009; Coyaud et al., 2010b; Lee et al., 2012). 
The PAX5 fusion partners comprise a 
heterogeneous group of genes that encode 
transcription factors, structural proteins, kinases, as 
well as several genes with so far unknown 
functions. 
AUTS2 
Location 
7q11.22 
DNA/RNA 
19 exons, alternatively spliced transcript variants 
encoding different isoforms. 
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Figure 1. Schematic representation of the structure of AUTS2 (top) and PAX5 (bottom) wild-type proteins as well as the putative 
consensus chimeric protein (middle). PD: paired domain; OP: octapeptide; HD: partial homeodomain; TA: transactivation 
domain; I: inhibitory domain; H: histidine-rich regions; P: proline-rich region; arrows indicate nuclear localization signals (NLS); 
filled lollipops represent serine phosphorylation sites. 
 
Protein 
AUTS2, is a highly conserved nuclear protein with 
so far unknown function, contains several putative 
N-terminal nuclear localization signals (NLS), two 
proline alternating with two histidine-rich regions, 
and two potential serine phosphorylation sites. It is 
strongly expressed in fetal and adult brain, 
particularly in the frontal, parietal, and temporal 
lobes. Mutations in the gene have been associated 
with autism and mental retardation (Oksenberg and 
Ahituv, 2013). 
Result of the chromosomal 
anomaly 
Hybrid gene 
Transcript 
In-frame fusions between PAX5 exon 6 and 
AUTS2 exon 4, 5 or 6 have been described 
(Kawamata et al., 2008; Coyaud et al., 2010; Denk 
et al., 2012). 
Fusion protein 
Description 
The putative consensus chimeric protein contains 
the DNA-binding paired domain, the octapeptide, 
and the partial homeodomain of PAX5 fused to the 
C-terminal regions of AUTS2. 
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